Main Page

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (05:44, 26 November 2019) (edit) (undo)
m (Protected "Main Page" [edit=sysop:move=sysop] [cascading])
 
(14 intermediate revisions not shown.)
Line 8: Line 8:
<span style="border:none; margin:0; padding:0.3em; color:#000; font-style: italic; font-size: 1.1em;max-width:80%;display:block;">
<span style="border:none; margin:0; padding:0.3em; color:#000; font-style: italic; font-size: 1.1em;max-width:80%;display:block;">
-
Its goal is to present this information in a user-friendly manner to a broad scientific audience as a free, collaborative '''3D-encyclopedia''' of proteins & other molecules.
+
<b>Proteopedia</b> presents this information in a user-friendly way as a '''collaborative & free 3D-encyclopedia of proteins & other biomolecules.'''
</span>
</span>
Line 15: Line 15:
<tr>
<tr>
-
<th style="padding: 10px;background-color: #33ff7b">Selected Pages</th>
+
<th style="padding: 10px;background-color: #33ff7b">Selected Research Pages</th>
-
<th style="padding: 10px;background-color: #f1b840">Journals</th>
+
<th style="padding: 10px;background-color: #f1b840">In Journals</th>
<th style="padding: 10px;background-color: #79baff">Education</th>
<th style="padding: 10px;background-color: #79baff">Education</th>
</tr>
</tr>
-
<tr>
+
<tr valign='top'>
<td style="padding: 5px;"> {{Proteopedia:Featured SEL/{{#expr: {{#time:U}} mod {{Proteopedia:Number of SEL articles}}}}}}</td>
<td style="padding: 5px;"> {{Proteopedia:Featured SEL/{{#expr: {{#time:U}} mod {{Proteopedia:Number of SEL articles}}}}}}</td>
<td style="padding: 5px;"> {{Proteopedia:Featured JRN/{{#expr: {{#time:U}} mod {{Proteopedia:Number of JRN articles}}}}}}</td>
<td style="padding: 5px;"> {{Proteopedia:Featured JRN/{{#expr: {{#time:U}} mod {{Proteopedia:Number of JRN articles}}}}}}</td>
Line 60: Line 60:
<td>[[Proteopedia:About|About]]</td>
<td>[[Proteopedia:About|About]]</td>
<td>[[Special:Contact|Contact]]</td>
<td>[[Special:Contact|Contact]]</td>
 +
<td>[[Template:MainPageNews|Hot News]]</td>
<td>[[Proteopedia:Table of Contents|Table of Contents]]</td>
<td>[[Proteopedia:Table of Contents|Table of Contents]]</td>
<td>[[Proteopedia:Structure Index|Structure Index]]</td>
<td>[[Proteopedia:Structure Index|Structure Index]]</td>

Current revision

ISSN 2310-6301

As life is more than 2D, Proteopedia helps to bridge the gap between 3D structure & function of biomacromolecules

Proteopedia presents this information in a user-friendly way as a collaborative & free 3D-encyclopedia of proteins & other biomolecules.


Selected Research Pages In Journals Education
About this image
The ribosome

by Wayne Decatur
The 2009 Nobel Prize in Chemistry was awarded for studies of the ribosome. The ribosome is the machine in your cells that accurately and efficiently decodes the genetic information stored in your genome and synthesizes the corresponding polypeptide chain one amino acid at a time in the process of translation. These structures are considered landmarks for the fact they showed clearly the major contributions to decoding and peptide bond synthesis come from RNA and not protein, as well as for the sheer size of the structures determined.

>>> Visit this page >>>

About this image
Interconversion of the specificities of human lysosomal enzymes associated with Fabry and Schindler diseases.

IB Tomasic, MC Metcalf, AI Guce, NE Clark, SC Garman. J. Biol. Chem. 2010 doi: 10.1074/jbc.M110.118588
The human lysosomal enzymes α-galactosidase and α-N-acetylgalactosaminidase share 46% amino acid sequence identity and have similar folds. Using a rational protein engineering approach, we interconverted the enzymatic specificity of α-GAL and α-NAGAL. The engineered α-GAL retains the antigenicity but has acquired the enzymatic specificity of α-NAGAL. Conversely, the engineered α-NAGAL retains the antigenicity but has acquired the enzymatic specificity of the α-GAL enzyme. Comparison of the crystal structures of the designed enzyme to the wild-type enzymes shows that active sites superimpose well, indicating success of the rational design. The designed enzymes might be useful as non-immunogenic alternatives in enzyme replacement therapy for treatment of lysosomal storage disorders such as Fabry disease.

>>> Visit this I3DC complement >>>

About this image
Transport of Drugs & Nutrients

Above is a transmembrane protein that takes up, into your intestinal cells, orally consumed peptide nutrients and drugs. Its lumen-face (shown above) opens and binds peptide or drug, then closes, while its cytoplasmic face (opposite end from the above) opens to release its cargo into the intestinal cell, which passes it on into the blood circulation.

>>> See more animations and explanation >>>

How to add content to Proteopedia

Video Guides

Who knows ...

About Interactive 3D Complements - I3DCs

List of I3DCs

How to get an I3DC for your paper

Teaching strategies using Proteopedia

Examples of pages for teaching

How to add content to Proteopedia

About Contact Hot News Table of Contents Structure Index Help

Proteopedia Page Contributors and Editors (what is this?)

Joel L. Sussman, Jaime Prilusky

Personal tools